- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Clinical efficacy of TroVax in the treatment of progressive castration-resistant prostate cancer - Abstract
February 10, 2012
Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia - Abstract
February 10, 2012
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review - Abstract
February 10, 2012
Does antibiotherapy prevent unnecessary prostate biopsies in patients with high PSA values? - Abstract
February 10, 2012
WCE 2011 - What should we measure? Predicting outcomes with flexible ureteroscopy for large renal stones - Session Highlights
February 10, 2012
WCE 2011 - Human versus robot: Who can perform more accurate prostate biopsy? - Session Highlights
February 10, 2012
The emerging role of diffusion-weighted MRI in prostate cancer management - Abstract
February 9, 2012
Seven years of experience with high-intensity focused ultrasound for prostate cancer: Advantages and limitations - Abstract
February 9, 2012
Distinct redox profiles of selected human prostate carcinoma cell lines: Implications for rational design of redox therapy - Abstract
February 8, 2012
Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era - Abstract
February 8, 2012
Understanding variation in primary prostate cancer treatment within the Veterans Health Administration - Abstract
February 8, 2012
Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer - Abstract
February 8, 2012